| Annovis Bio Gets $12M in IPO to Target Trio of Neurotoxic Proteins | Sarah de Crescenzo | 01/29/20 | New York |
| Prenatal Screener Natera Grabs $55M, Considers Cancer Test | David Holley | 04/06/15 | San Francisco |
| Ariosa Takes Pre-Natal Genetic Test to Wall Street, Eyes $69M IPO | Ben Fidler | 03/25/14 | San Francisco |
| San Diego Life Sciences Roundup: Thesan, Zogenix, Illumina, and More | Bruce V. Bigelow | 02/28/14 | San Diego |
| San Diego Life Sciences Roundup: Regulus, Ocera, Lithera, and More | Bruce V. Bigelow | 07/18/13 | San Diego |
| Natera Grabs $55M For Push into Prenatal Genetic Screening | Luke Timmerman | 05/01/13 | San Francisco |
| Illumina Acquires Verinata Health, Prenatal Testmaker, For $350M | Luke Timmerman | 01/07/13 | San Diego |
| San Diego Life Sciences Roundup: Regulus, Aragon, Cytori, & More | Bruce V. Bigelow | 10/05/12 | San Diego |
| Gene Security Network, Now Natera, Adds $20M For Prenatal Tests | Luke Timmerman | 01/06/12 | San Francisco |
| Roche Acquires Anadys, Wests Create $100M Fund, Johnson & Johnson Makes Room for 20 Startups, & More San Diego Life Sciences News | Bruce V. Bigelow | 10/20/11 | San Diego |
| Sequenom Inaugurates New Diagnostic Test for Down Syndrome | Bruce V. Bigelow | 10/17/11 | San Diego |
| Sequenom, Illumina Team Up on Down Syndrome Test | Tom Abate | 07/11/11 | San Diego |
| Sequenom Builds Lab to Screen Test Results | Bruce V. Bigelow | 08/17/10 | San Diego |
| Sequenom’s Former R&D Chief Pleads Guilty to Securities Fraud Charge | Bruce V. Bigelow | 06/02/10 | San Diego |
| Sequenom Restarts Down Syndrome Test, Cytori Upbeat About Cardiac Study, Pathway Genomics Mass Markets Genome Tests, & More San Diego Life Sciences News | Denise Gellene | 05/13/10 | San Diego |
| Sequenom Raises $51.6 Million As It Prepares to Restart Down Syndrome Test | Denise Gellene | 05/12/10 | San Diego |
| Sequenom Restarting Development of Diagnostic Test for Down Syndrome | Bruce V. Bigelow | 05/06/10 | San Diego |
| Avalon Raising New Fund, Althea Technologies Gets Altus Assets, Trancon Pharmaceuticals Nabs Financing, & More San Diego Life Sciences News | Denise Gellene | 05/06/10 | San Diego |
| Sequenom Speaks Out, Amylin Receives a Setback, Somaxon Awaits FDA Decision, & More San Diego Life Sciences News | Denise Gellene | 03/18/10 | San Diego |
| San Diego’s Sequenom Steps Back Into the Spotlight, Sort Of | Bruce V. Bigelow | 03/17/10 | San Diego |
| Sequenom Settles Shareholder Lawsuit for $14M, Plus Stock | Luke Timmerman | 01/15/10 | San Diego |
| Sequenom Settles SensiGen Claims | Bruce V. Bigelow | 01/04/10 | San Diego |
| Sequenom Looks to Prolong Operations as Available Cash Runs Low | Denise Gellene | 11/10/09 | San Diego |
| New York Biotech Sues Sequenom for Fraud | Denise Gellene | 10/29/09 | San Diego |
| Justice Department Joins Sequenom Probe, Accumetrics Raises $16.5, Transdel’s Topical Pain Reliever Gets Mixed Results, & More San Diego Life Sciences News | Denise Gellene | 10/08/09 | San Diego |
| Sequenom Meets With FBI, U.S. Attorney’s Office Investigators | Luke Timmerman | 10/05/09 | San Diego |
| Sequenom Starts Over After Purge, Patent Lawsuits Flying Over Gene Sequencing Technologies, Zogenix Prepares for Needle-Free Injections, & More San Diego Biotech News | Bruce V. Bigelow | 10/01/09 | San Diego |
| Sequenom Shares Tank After Executives Ousted Over Data Mishandling | Luke Timmerman | 09/28/09 | San Diego |
| Sequenom Ousts CEO Harry Stylli, After Investigating Mishandling of Down Syndrome Test | Luke Timmerman | 09/28/09 | San Diego |
| Domain Raises a $500M VC Fund, Dissident Prods Amylin Again, Avanir Passes Pivotal Test, & More San Diego Life Sciences News | Bruce V. Bigelow | 08/13/09 | San Diego |
